There were no significant losers this week, although OPTI:Optibiotix dropped 1p which cost me £1,000. It's great news that I only ended up £107 down considering that.
JLP:Jubilee Metals is starting to nudge higher as Kabwe progress is looking good. They climbed 7% but are still down by 29% overall.
Share of the Week is CAML:Central Asia Metals which had great interim results and held the dividend despite industrial metals prices being really low. They responded by climbing 9% which took them back into profit and 4% up. So glad I sold 40% of my holding to buy OPTI:Optibiotix and SBTX:SkinBioTherapeutics which have stayed flat since I bought them. I very rarely seem to time anything right.
Only just above the orange line by a few hundred quid. The mountain caused by OPTI:Optibiotix climbing to 134p just over a year ago has well and truly left the chart
Here's the ISA and share accounts
| Weekly Change | |||
| Cash | £6.36 | +£0 | |
| Portfolio cost | £57,768.95 | +£0 | |
| Portfolio sell value (bid price-commission) | £35,463.58 | (-38.6%) | -£254.77 |
| Potential profits | £0 | +£0 | |
| Yr 5 Dividends | £0 | +£0 | |
| Yr 5 Profit from sales | £-167.28 | +£0 | |
| Yr 5 Average monthly cash profit | -£105.88 | (-2.2%) | +£17.64 |
| Total Dividends | £1,342.30 | +£0 | |
| Total Profit from sales | £20,224.13 | +£0 | |
| Average monthly cash profit | £430.74 | (8.9%) | -£2.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
Most of the damage done by OPTI:Optibiotix falling 1p but mitigated by the rise in JLP:Jubilee Metals. Not enough to prevent a drop though. Average profit drops below 9% but there's nothing available to sell in order to improve it.
Still below the cash injection line so still utterly dire.
It needs £10,000 just to get up to the declining trend line, so really in a desperate state.
The SIPP looks like this after week 199
| Weekly Change | ||||
| Cash | £17.96 | +£0 | ||
| Portfolio cost | £43,965.42 | +£0 | ||
| Portfolio sell value (bid price - commission) |
£30,863.68 | (-29.8%) | +£132.76 | |
| Potential profits | £227.97 | +£227.97 | ||
| Yr 4 Dividends | £361.99 | +£0 | ||
| Yr 4 Interest | £0.10 | +£0 | ||
| Yr 4 Profit from sales | £1,161.95 | +£0 | ||
| Yr 4 Average monthly cash profit | £140.05 | (3.8%) | -£3.34 | |
| Total Dividends | £1,704.24 | +£0 | ||
| Total Interest | £0.13 | +£0 | ||
| Total Profit from sales | £11,706.87 | +£0 | ||
| Average monthly cash profit | £282.97 | (7.7%) | -£1.43 | |
| (Sold stocks profit + Dividends - Fees / Months) |
The good rise in CAML:Central Asia Metals overcame the OPTI:Optibiotix drop and also means there is a potential profit to record. Average performance down to 7.7% so well below target 10%, but at the moment I'm more concerned about paper value being 30% down on purchase price.
This account was in the black for a long, long time. Now I'm celebrating the fact it's just above the cash injection value.
As with the ISA, this account is on a similar trajectory of decline, but needs about £7,000 to get back above the trend line
The trading account looks like this after week 165
| Weekly Change | |||
| Cash | £35.04 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,291.54 | (-44.4%) | +£14.32 |
| Potential profits | £0 | +£0 | |
| Year 4 Dividends | £0 | +£0 | |
| Year 4 Profit | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £0 | (0%) | +£0 |
| Dividends | £34.72 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.78 | (-0.4%) | +£0 |
| (Sold stocks profit + Dividends - Fees / Months) |
The rise in CAML:Central Asia Metals and a small rise in IQE:IQE were enough to keep the drops in TEK:Tekcapital and TRMR:Tremor pulling it into the red for the week. How quickly will the 19% deficit be made up by CAML? Hopefully not before the dividend ex-date in October as I may as well get that. Broker target is 310p which would give me 24% profit. My target is a more modest 290p (16%) which will put the account into the black on average performance.
We're above the trend line! I'm not overly optimistic about the short term prospects though. Long term reasonably happy, but this isn't meant to be a long term account.
Here's my efforts in the fantasy share game
An excellent week, climbing 751 places from 1,542nd to 791st. Unfortunately this is the last week and the game has closed. Not sure if that's it, but I'll try again if they launch a new one. I finally sussed out the rules. Your performance is taken on the average of each of your percentage gains or losses. So if you sell a share, you bank the percentage gain, and if you sell one that's losing, you take a hit but prevent that percentage getting bigger. I hope they do launch a new one as I think I've got the hang of it now.
Nearly all the shares improved this week, particularly CAML:Central Asia Metals, so it was a nice end and explains my leap up the league as the shares that are up are up much more than the shares that are down.
MMX:Minds + Machines should be reporting interims on Tuesday as they have an analyst presentation booked. I'm hoping this will give the price a lift. My initial thought is that I'll get rid as soon as I can, but a lot depends on how bullish the interims are. There is potential for a low cost high revenue dividend-paying company here. They were cash rich but spent it acquiring a company, which is good if that proves to be bringing in revenues.
TRMR:Tremor are also due to give interims on Tuesday. I really haven't a clue what to expect from them, but it's unlikely to make much of an improvement in the 50% decline since I bought them. We can but hope. All will be revealed on Tuesday...
No comments:
Post a Comment